The report “Hemodialysis and Peritoneal Dialysis Market by Product (Machine, Bloodline, Concentrate (Alkaline), Catheter, Dialyzer, Water Treatment, Services), Modality (CAPD, Nocturnal), User (Hospital, Home Care) – Global Forecast to 2029″, is projected to reach USD 126.2 billion by 2029 from USD 92.0 billion in 2024 at a CAGR of 6.5% during the forecast period.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=1279
Browse
- 150 Market Data Tables
- 65 Figures
- 350 Pages and in-depth TOC on “ Hemodialysis and Peritoneal Dialysis Market – Global Forecast to 2029”
Some of the prominent key players are:
- Fresenius Medical Care AG & Co. KGaA (Germany),
- Baxter International Inc. (US),
- Nipro Corporation (Japan),
- NIKKISO CO., LTD. (Japan), and many more……
Mergers & acquisitions, investments & expansions, partnerships & collaborations, and new product developments are some of the major strategies adopted by these key players to enhance their positions in the Hemodialysis and Peritoneal Dialysis Market .
Growth Driver: Rising prevalence of chronic kidney disease globally
The rising prevalence of chronic kidney disease (CKD) globally is expected to significantly drive the hemodialysis and peritoneal dialysis market. Chronic kidney disease is likely to affect more than 10% of the population worldwide as chronic kidney disease becomes more prevalent due to factors such as aging populations, increasing rates of diabetes and hypertension, increasing the CKD progression to end-stage renal diseases, necessitating the dialysis. Chronic kidney disease (CKD) is more prevalent among individuals aged 65 years or older. According to Centres of Disease Control and Prevention (CDC), an estimated 35.5 million people in US were diagnosed with CKD in 2023.
Opportunity: High growth potential of emerging markets
Emerging markets such as China, India, Brazil, are expected to offer significant growth opportunities for players operating in the POC diagnostics market. This is primarily due to the high and growing prevalence of diabetes, chronic kidney diseases, in these countries. As economic growth in China and India continues to expand, there is rise in healthcare spending across these countries, which leads to improved affordability of hemodialysis and peritoneal dialysis treatment. According to the article published by BMC Nephrology in 2023, in China, the prevalence of ESRD is projected to reach 1,505 patients per million population by 2025. To meet the increasing demand for dialysis in the emerging markets, players focus on acquiring or entering into agreements and partnerships with healthcare providers.
- The hemodialysis market is segmented based on product and service. Hemodialysis products include hemodialysis machines and hemodialysis consumables & supplies, whereas hemodialysis services include in-center services and home services. The hemodialysis services segment is anticipated to grow at significant rate during the forecast period.
- Based on end users, home care setting is expected to grow at a significant rate owing to growing preference of patients for home hemodialysis modality, technological advancements, and the cost-effectiveness of home dialysis treatment over incentre dialysis procedures.
- On the basis of region, the hemodialysis and peritoneal dialysis market is segmented into North America, Europe, Asia Pacific, and the Latin America, Middle East & Africa. The Asia-Pacific market is likely to witness significant market growth. This is attributed to the rise in geriatric patient population, increasing cases of chronic kidney diseases, moreover improving healthcare infrastructure and the implementation of supportive government initiatives to increase the accessibility of dialysis services in many APAC countries such as India and China.
Recent Developments of Hemodialysis and Peritoneal Dialysis Industry:
- In July 2023, Rockwell Medical acquired the hemodialysis concentrates business from Evoqua Water Technologies, strengthening its presence in the hemodialysis market
- In January 2022, Nextkidney BV acquired Dialyss Pte Ltd, enhancing its technology capabilities in home hemodialysis
- In March 2021, DaVita Inc. signed an agreement with Fresenius Medical Care AG & Co. KGaA for the expansion of the usage of NxStage Home Hemodialysis Machines
The escalating global prevalence of chronic kidney disease, spurred by growing aging population coupled with the increasing cases of diabetes and hypertension are fuelling the demand for renal replacement therapy including hemodialysis and peritoneal dialysis products and services. Ongoing technological advancements in dialysis technology, growing patient preference of home dialysis, supporting reimbursement policies and government initiatives and funding for healthcare infrastructure, enabling expansion of hospitals and dialysis centers further enhancing the accessibility of hemodialysis and peritoneal dialysis services among patients with end-stage renal disease (ESRD) are likely to drive the market growth during the forecast period.
Related News :-
